PR84761

SINGAPORE, July 14, 2020 /PRNewswire=KYODO JBN/ --

Zuellig Pharma, a leading healthcare services provider in Asia, announces the

appointment of John Graham as its new CEO. John will run the US$13 billion

business and lead the team across 13 markets in Asia.

Photo - https://photos.prnasia.com/prnh/20200713/2855812-1 

He joined Zuellig Pharma in 2018 to oversee the development and growth of

Zuellig Pharma's Commercial Solutions business, spearheading the growth of its

marketing, sales, business development and regulatory services. He takes over

the helm from former CEO John Davison who retired at the end of last month.

John has over three decades of industry experience in biotech, pharmaceuticals,

strategy consulting and healthcare investment banking across Europe, Asia,

Latin America and the United States. He previously held various senior global

leadership positions at Aventis, Genzyme and Ernst & Young, as well as the role

of CEO at Menarini Asia-Pacific based in Singapore, where he established the

company's Asia-Pacific commercial footprint.

"John brings with him a strong track record of strategic and operational

leadership through the various global roles he has held. In his time with

Zuellig Pharma, John has also driven unparalleled success in the Commercial

Solutions business. We look forward to working closely with him to continue to

transform the organisation and execute our exciting growth plans," said Patrick

Davies, Chairman of Zuellig Pharma.

"Over the next few years, my goal is to transform Zuellig Pharma into a major

integrated healthcare business that is indispensable to industry stakeholders

and has a major impact on society. Together, we will continue to pursue our

mission to make healthcare more accessible through providing world-class,

innovative solutions to our partners and customers in distribution, commercial

and digital technology," said John.

John assumed his new role on 1 July this year and is based in Zuellig Pharma's

headquarters in Singapore.

About Zuellig Pharma

Zuellig Pharma is one of the largest healthcare services groups in Asia and our

purpose is to make healthcare more accessible. We provide world-class

distribution, commercial and digital services to support the growing healthcare

needs in this region.

The company started almost a hundred years ago and has grown to become a US$13

billion business covering 13 markets with 12,000 employees. We serve over

350,000 medical facilities and work with more than 500 clients, including the

top 20 pharmaceutical companies in the world.

More recently, we launched our Zuellig Health Solutions Innovation Centre to

develop new services and address some pressing healthcare needs in Asia. Since

then, our teams have been focused on creating data, digital and disease

management solutions, supporting patients with chronic conditions and helping

payors manage healthcare costs.

SOURCE Zuellig Pharma

Image Attachments Links:

   Link: http://asianetnews.net/view-attachment?attach-id=367322 

   Caption: John Graham, Zuellig Pharma’s newly appointed Chief Executive Officer